A Positron Emission Tomography (PET) Study to Evaluate Dopamine D2 and D3 Receptor Occupancy by SIPI6398

NCT07626034 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia Disorder

Interventions

DRUG: SIPI6398 Tablets

Sponsor

Shanghai Zhongze Therapeutics Co., Ltd.

Collaborators

[object Object]